Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy

It is not known whether the addition of ezetimibe to statins adds cardiovascular protection beyond the expected changes in lipid levels. Subjects with coronary heart disease were treated with four consecutive 1-week courses of therapy (T) and evaluations. The courses were: T1, 100 mg aspirin alone;...

Descripción completa

Detalles Bibliográficos
Autores principales: Camargo, L.M., França, C.N., Izar, M.C., Bianco, H.T., Lins, L.S., Barbosa, S.P., Pinheiro, L.F., Fonseca, F.A.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2014
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075313/
https://www.ncbi.nlm.nih.gov/pubmed/24760119
http://dx.doi.org/10.1590/1414-431X20143628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075313/
https://www.ncbi.nlm.nih.gov/pubmed/24760119
http://dx.doi.org/10.1590/1414-431X20143628

Ejemplares similares